Cholesterol metabolism and resistance to tamoxifen. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Current Opinion in Pharmacology Year : 2012

Cholesterol metabolism and resistance to tamoxifen.


The oncoprotein MUC-1 was shown to upregulate the transcription of genes encoding cholesterol and lipid metabolic enzymes and correlated with a resistance to Tamoxifen (Tam) despite the presence of estrogen receptor α in breast cancer tumors. The importance of this observation is supported by molecular studies on Tam suggesting two additional pharmacological targets involved in cholesterol metabolism. These observations demonstrate the potential importance of cholesterol and lipid metabolism in the pharmacology/therapeutic effects of Tam.

Dates and versions

inserm-00743466 , version 1 (19-10-2012)



Marc Poirot, Sandrine Silvente-Poirot, Ralph R. Weichselbaum. Cholesterol metabolism and resistance to tamoxifen.. Current Opinion in Pharmacology, 2012, 12 (6), pp.683-9. ⟨10.1016/j.coph.2012.09.007⟩. ⟨inserm-00743466⟩
84 View
0 Download



Gmail Facebook X LinkedIn More